Piramal Pharma Ltd: Piramal Pharma unveils its Sustainability Report FY21-22, articulating its ESG journey to accelerate the pace of integrating sustainability practices
The Report articulates PPL's ESG strategic and operational framework, and execution roadmap, including specific objective targetsThe Report is prepared in accordance with GRI Standards and highlights